Literature DB >> 23688234

Hit identification and optimization in virtual screening: practical recommendations based on a critical literature analysis.

Tian Zhu1, Shuyi Cao, Pin-Chih Su, Ram Patel, Darshan Shah, Heta B Chokshi, Richard Szukala, Michael E Johnson, Kirk E Hevener.   

Abstract

A critical analysis of virtual screening results published between 2007 and 2011 was performed. The activity of reported hit compounds from over 400 studies was compared to their hit identification criteria. Hit rates and ligand efficiencies were calculated to assist in these analyses, and the results were compared with factors such as the size of the virtual library and the number of compounds tested. A series of promiscuity, druglike, and ADMET filters were applied to the reported hits to assess the quality of compounds reported, and a careful analysis of a subset of the studies that presented hit optimization was performed. These data allowed us to make several practical recommendations with respect to selection of compounds for experimental testing, definition of hit identification criteria, and general virtual screening hit criteria to allow for realistic hit optimization. A key recommendation is the use of size-targeted ligand efficiency values as hit identification criteria.

Entities:  

Mesh:

Year:  2013        PMID: 23688234      PMCID: PMC3772997          DOI: 10.1021/jm301916b

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  58 in total

1.  VolSurf: a new tool for the pharmacokinetic optimization of lead compounds.

Authors:  G Cruciani; M Pastor; W Guba
Journal:  Eur J Pharm Sci       Date:  2000-10       Impact factor: 4.384

Review 2.  Designing screens: how to make your hits a hit.

Authors:  W Patrick Walters; Mark Namchuk
Journal:  Nat Rev Drug Discov       Date:  2003-04       Impact factor: 84.694

3.  Consideration of molecular weight during compound selection in virtual target-based database screening.

Authors:  Yongping Pan; Niu Huang; Sam Cho; Alexander D MacKerell
Journal:  J Chem Inf Comput Sci       Date:  2003 Jan-Feb

4.  On outliers and activity cliffs--why QSAR often disappoints.

Authors:  Gerald M Maggiora
Journal:  J Chem Inf Model       Date:  2006 Jul-Aug       Impact factor: 4.956

5.  Discovery of highly selective inhibitors of human fatty acid binding protein 4 (FABP4) by virtual screening.

Authors:  Haiyan Cai; Guirui Yan; Xiaodong Zhang; Olena Gorbenko; Heyao Wang; Weiliang Zhu
Journal:  Bioorg Med Chem Lett       Date:  2010-04-24       Impact factor: 2.823

6.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

Authors:  Jonathan B Baell; Georgina A Holloway
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

7.  Design, Synthesis and Biological Evaluation of a Series of Novel Axl Kinase Inhibitors.

Authors:  Alexis Mollard; Steven L Warner; Lee T Call; Mark L Wade; Jared J Bearss; Anupam Verma; Sunil Sharma; Hariprasad Vankayalapati; David J Bearss
Journal:  ACS Med Chem Lett       Date:  2011-12-08       Impact factor: 4.345

8.  Discovery and optimization of a novel spiropyrrolidine inhibitor of β-secretase (BACE1) through fragment-based drug design.

Authors:  Ivan V Efremov; Felix F Vajdos; Kris A Borzilleri; Steven Capetta; Hou Chen; Peter H Dorff; Jason K Dutra; Steven W Goldstein; Mahmoud Mansour; Alexander McColl; Stephen Noell; Christine E Oborski; Thomas N O'Connell; Theresa J O'Sullivan; Jayvardhan Pandit; Hong Wang; Binqing Wei; Jane M Withka
Journal:  J Med Chem       Date:  2012-05-09       Impact factor: 7.446

9.  Rules for identifying potentially reactive or promiscuous compounds.

Authors:  Robert F Bruns; Ian A Watson
Journal:  J Med Chem       Date:  2012-10-25       Impact factor: 7.446

Review 10.  Rational methods for the selection of diverse screening compounds.

Authors:  David J Huggins; Ashok R Venkitaraman; David R Spring
Journal:  ACS Chem Biol       Date:  2011-02-15       Impact factor: 5.100

View more
  57 in total

1.  Molecular Scaffold Hopping via Holistic Molecular Representation.

Authors:  Francesca Grisoni; Gisbert Schneider
Journal:  Methods Mol Biol       Date:  2021

2.  First virtual screening and experimental validation of inhibitors targeting GES-5 carbapenemase.

Authors:  Francesca Spyrakis; Pierangelo Bellio; Antonio Quotadamo; Pasquale Linciano; Paolo Benedetti; Giulia D'Arrigo; Massimo Baroni; Laura Cendron; Giuseppe Celenza; Donatella Tondi
Journal:  J Comput Aided Mol Des       Date:  2019-01-02       Impact factor: 3.686

3.  In Silico Prediction of Major Clearance Pathways of Drugs among 9 Routes with Two-Step Support Vector Machines.

Authors:  Naomi Wakayama; Kota Toshimoto; Kazuya Maeda; Shun Hotta; Takashi Ishida; Yutaka Akiyama; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2018-08-24       Impact factor: 4.200

4.  A virtual screen discovers novel, fragment-sized inhibitors of Mycobacterium tuberculosis InhA.

Authors:  Alexander L Perryman; Weixuan Yu; Xin Wang; Sean Ekins; Stefano Forli; Shao-Gang Li; Joel S Freundlich; Peter J Tonge; Arthur J Olson
Journal:  J Chem Inf Model       Date:  2015-02-17       Impact factor: 4.956

5.  LBVS: an online platform for ligand-based virtual screening using publicly accessible databases.

Authors:  Minghao Zheng; Zhihong Liu; Xin Yan; Qianzhi Ding; Qiong Gu; Jun Xu
Journal:  Mol Divers       Date:  2014-09-03       Impact factor: 2.943

6.  Machine learning on drug-specific data to predict small molecule teratogenicity.

Authors:  Anup P Challa; Andrew L Beam; Min Shen; Tyler Peryea; Robert R Lavieri; Ethan S Lippmann; David M Aronoff
Journal:  Reprod Toxicol       Date:  2020-05-16       Impact factor: 3.143

7.  A novel image-based high-throughput screening assay discovers therapeutic candidates for adult polyglucosan body disease.

Authors:  Leonardo J Solmesky; Netaly Khazanov; Hanoch Senderowitz; Peixiang Wang; Berge A Minassian; Igor M Ferreira; Wyatt W Yue; Alexander Lossos; Miguel Weil; Or Kakhlon
Journal:  Biochem J       Date:  2017-09-28       Impact factor: 3.857

8.  Discovery of a nanomolar inhibitor of the human glyoxalase-I enzyme using structure-based poly-pharmacophore modelling and molecular docking.

Authors:  Nizar A Al-Shar'i; Qosay A Al-Balas; Rand A Al-Waqfi; Mohammad A Hassan; Amer E Alkhalifa; Nehad M Ayoub
Journal:  J Comput Aided Mol Des       Date:  2019-10-19       Impact factor: 3.686

9.  Quantitative and systems pharmacology 4. Network-based analysis of drug pleiotropy on coronary artery disease.

Authors:  Jiansong Fang; Chuipu Cai; Yanting Chai; Jingwei Zhou; Yujie Huang; Li Gao; Qi Wang; Feixiong Cheng
Journal:  Eur J Med Chem       Date:  2018-10-15       Impact factor: 6.514

10.  Dual-inhibitors of STAT5 and STAT3: studies from molecular docking and molecular dynamics simulations.

Authors:  Shengjuan Shao; Rilei Yu; Yanqing Yu; Yanni Li
Journal:  J Mol Model       Date:  2014-08-07       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.